Invasive Treatment Tied to Better Outcomes in Elderly With NSTEMI

THURSDAY, Sept. 3, 2020 -- Invasive management is beneficial for patients with non-ST elevation myocardial infarction (NSTEMI) aged 80 years or older, according to a study published online Aug. 27 in The Lancet. Amit Kaura, M.B.Ch.B., from Imperial...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news